Rajeshwari Sridhara

FDA Drug Approval Summary: Gefitinib (ZD1839) (Iressa®) Tablets

Martin H. Cohen, Grant A. Williams, Rajeshwari Sridhara et al. · The Oncologist · 2003 · 577 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +10

United States Food and Drug Administration Drug Approval Summary

Martin H. Cohen, Grant A. Williams, Rajeshwari Sridhara et al. · Clinical Cancer Research · 2004 · 500 citations

Medicine, Oncology, Pharmacology +15

Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement

Edward S. Kim, Suanna S. Bruinooge, Samantha Roberts et al. · Journal of Clinical Oncology · 2017 · 482 citations

Medicine, Child Health, Clinical Trial Regulation +16

FDA Drug Approval Summary: Erlotinib (Tarceva®) Tablets

Martin H. Cohen, John R. Johnson, Yeh‐Fong Chen et al. · The Oncologist · 2005 · 441 citations

Medicine, Oncology, Pharmacology +14

Analysis of the Association Between Adverse Events and Outcome in Patients Receiving a Programmed Death Protein 1 or Programmed Death Ligand 1 Antibody

V. Ellen Maher, Laura L. Fernandes, Chana Weinstock et al. · Journal of Clinical Oncology · 2019 · 346 citations

Medicine, Oncology, Pharmacology +17